As the nation confronts the ongoing substance use disorder and overdose crisis, APhA is continuing to advocate for pharmacists to be recognized as essential members of the care team. In this blog, CEO Michael Hogue reflects on the release of the new National Drug Control Strategy, the lives impacted by addiction, and the critical role pharmacists play in prevention, treatment, recovery, and connecting patients to care.

WASHINGTON, DC (April 9, 2026) — The American Pharmacists Association (APhA) is pleased to announce that Melissa Somma McGivney, PharmD, FCCP, FAPhA, will join the organization as its inaugural Chief of Professional and Member Experience, effective June 1, 2026.

On November 15, DEA announced the extension of current telemedicine flexibilities for prescription-controlled medications through the end of 2025. This includes substances such as buprenorphine and Adderall.

Resting heart rate was associated with an increased risk of new-onset AFib for Black adults, according to a recent study published in JAMA Network Open.